{"actionType":"INHIBITOR","mechanismOfAction":"Topoisomerase IV inhibitor","chemblIds":["CHEMBL31"],"targetName":"Topoisomerase IV","targetType":"protein complex","targets":[],"references":[{"source":"FDA","ids":["label/2015/021493s010lbl.pdf","label/2015/021493s010lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021493s010lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021493s010lbl.pdf"]}]}
{"mechanismOfAction":"SOD mimic (antioxidant)","chemblIds":["CHEMBL3544979"],"references":[{"source":"PubMed","ids":["33910826"],"urls":["https://pubmed.ncbi.nlm.nih.gov/33910826/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Peroxisome proliferator-activated receptor delta agonist","chemblIds":["CHEMBL38943"],"targetName":"Peroxisome proliferator-activated receptor delta","targetType":"single protein","targets":["ENSG00000112033"],"references":[{"source":"Other","ids":["https://www.sciencedirect.com/topics/neuroscience/gw501516"],"urls":["https://www.sciencedirect.com/topics/neuroscience/gw501516"]},{"source":"PubMed","ids":["16625823","25943561"],"urls":["http://europepmc.org/abstract/MED/16625823","http://europepmc.org/abstract/MED/25943561"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Asparagine hydrolytic enzyme","chemblIds":["CHEMBL2108989"],"references":[{"source":"DailyMed","ids":["setid=30bdf2ea-008b-4cbb-81e4-c3474f2ad286#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30bdf2ea-008b-4cbb-81e4-c3474f2ad286#nlm34090-1"]}]}
{"actionType":"NEGATIVE ALLOSTERIC MODULATOR","mechanismOfAction":"Serine/threonine-protein kinase AKT negative allosteric modulator","chemblIds":["CHEMBL4297329"],"targetName":"Serine/threonine-protein kinase AKT","targetType":"protein family","targets":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"references":[{"source":"Other","ids":["https://ashpublications.org/blood/article/120/21/942/87595/TAS-117-a-Novel-Selective-Akt-Inhibitor"],"urls":["https://ashpublications.org/blood/article/120/21/942/87595/TAS-117-a-Novel-Selective-Akt-Inhibitor"]},{"source":"PubMed","ids":["24934808","33723724"],"urls":["http://europepmc.org/abstract/MED/24934808","http://europepmc.org/abstract/MED/33723724"]},{"source":"ClinicalTrials","ids":["NCT03017521"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT03017521"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ig epsilon chain C region inhibitor","chemblIds":["CHEMBL2107888"],"targetName":"Ig epsilon chain C region","targetType":"single protein","targets":["ENSG00000211891"],"references":[{"source":"PubMed","ids":["12637608"],"urls":["http://europepmc.org/abstract/MED/12637608"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"p90RSK inhibitor","chemblIds":["CHEMBL4650277"],"targetName":"p90RSK","targetType":"protein family","targets":["ENSG00000177189","ENSG00000071242","ENSG00000072133","ENSG00000117676"],"references":[{"source":"PubMed","ids":["31879363","31879363","31879363"],"urls":["http://europepmc.org/abstract/MED/31879363","http://europepmc.org/abstract/MED/31879363","http://europepmc.org/abstract/MED/31879363"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Thrombopoietin receptor agonist","chemblIds":["CHEMBL2105758","CHEMBL2103883"],"targetName":"Thrombopoietin receptor","targetType":"single protein","targets":["ENSG00000117400"],"references":[{"source":"FDA","ids":["label/2018/210238s000lbl.pdf","nda/2018/210238Orig1s000MultidisciplineR.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210238s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210238Orig1s000MultidisciplineR.pdf"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Voltage-gated calcium channel alpha2/delta subunit 2 modulator","chemblIds":["CHEMBL3545257","CHEMBL3545125"],"targetName":"Voltage-gated calcium channel alpha2/delta subunit 2","targetType":"single protein","targets":["ENSG00000007402"],"references":[{"source":"PubMed","ids":["25231896","25231896"],"urls":["http://europepmc.org/abstract/MED/25231896","http://europepmc.org/abstract/MED/25231896"]},{"source":"Wikipedia","ids":["Mirogabalin","Mirogabalin"],"urls":["https://en.wikipedia.org/wiki/Mirogabalin","https://en.wikipedia.org/wiki/Mirogabalin"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Glycogen synthase kinase-3 alpha inhibitor","chemblIds":["CHEMBL362558"],"targetName":"Glycogen synthase kinase-3 alpha","targetType":"single protein","targets":["ENSG00000105723"],"references":[{"source":"PubMed","ids":["23305709","25915038","23305709","25915038"],"urls":["http://europepmc.org/abstract/MED/23305709","http://europepmc.org/abstract/MED/25915038","http://europepmc.org/abstract/MED/23305709","http://europepmc.org/abstract/MED/25915038"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Androgen Receptor agonist","chemblIds":["CHEMBL1201101"],"targetName":"Androgen Receptor","targetType":"single protein","targets":["ENSG00000169083"],"references":[{"source":"DailyMed","ids":["setid=cfbb53d4-b868-4a28-8436-f9112eb01c39#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39#nlm34090-1"]},{"source":"Wikipedia","ids":["Testosterone"],"urls":["http://en.wikipedia.org/wiki/Testosterone"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Sodium channel protein type V alpha subunit blocker","chemblIds":["CHEMBL1200612","CHEMBL1086"],"targetName":"Sodium channel protein type V alpha subunit","targetType":"single protein","targets":["ENSG00000183873"],"references":[{"source":"PubMed","ids":["8798723","9742684","8798723","9742684"],"urls":["http://europepmc.org/abstract/MED/8798723","http://europepmc.org/abstract/MED/9742684","http://europepmc.org/abstract/MED/8798723","http://europepmc.org/abstract/MED/9742684"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Complement factor B inhibitor","chemblIds":["CHEMBL4594448"],"targetName":"Complement factor B","targetType":"single protein","targets":["ENSG00000243649"],"references":[{"source":"Other","ids":["https://www.novartis.com/news/media-releases/novartis-presents-promising-interim-phase-ii-data-potential-first-class-oral-therapy-iptacopan-lnp023-rare-renal-disease-c3-glomerulopathy-c3g","https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00028-4/fulltext"],"urls":["https://www.novartis.com/news/media-releases/novartis-presents-promising-interim-phase-ii-data-potential-first-class-oral-therapy-iptacopan-lnp023-rare-renal-disease-c3-glomerulopathy-c3g","https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00028-4/fulltext"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Matrix metalloproteinase 13 inhibitor","chemblIds":["CHEMBL3989740","CHEMBL1433"],"targetName":"Matrix metalloproteinase 13","targetType":"single protein","targets":["ENSG00000137745"],"references":[{"source":"DailyMed","ids":["setid=3105a84b-655e-4940-9d11-4209cdb05d6b","setid=3105a84b-655e-4940-9d11-4209cdb05d6b","setid=3105a84b-655e-4940-9d11-4209cdb05d6b","setid=bfd09049-1777-43e7-bf79-ceea4bdce13b","setid=3105a84b-655e-4940-9d11-4209cdb05d6b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b","https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfd09049-1777-43e7-bf79-ceea4bdce13b","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b"]},{"source":"PubMed","ids":["17199549","20370419","20592239","17199549","20370419","20592239","17199549","20370419","20592239","27246781","17199549","20370419","20592239"],"urls":["http://europepmc.org/abstract/MED/17199549","http://europepmc.org/abstract/MED/20370419","http://europepmc.org/abstract/MED/20592239","http://europepmc.org/abstract/MED/17199549","http://europepmc.org/abstract/MED/20370419","http://europepmc.org/abstract/MED/20592239","http://europepmc.org/abstract/MED/17199549","http://europepmc.org/abstract/MED/20370419","http://europepmc.org/abstract/MED/20592239","http://europepmc.org/abstract/MED/27246781","http://europepmc.org/abstract/MED/17199549","http://europepmc.org/abstract/MED/20370419","http://europepmc.org/abstract/MED/20592239"]}]}
{"actionType":"POSITIVE ALLOSTERIC MODULATOR","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","chemblIds":["CHEMBL3989949"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"PubMed","ids":["31063770","31063770"],"urls":["http://europepmc.org/abstract/MED/31063770","http://europepmc.org/abstract/MED/31063770"]},{"source":"FDA","ids":["label/2019/212839s000lbl.pdf","label/2019/212839s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL1909072"],"references":[{"source":"Other","ids":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613578/pdf/annsurg01301-0002.pdf"],"urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613578/pdf/annsurg01301-0002.pdf"]},{"source":"DOI","ids":["10.1007/BF03021345"],"urls":["https://link.springer.com/article/10.1007/BF03021345"]}]}
{"mechanismOfAction":"Mycolytic","chemblIds":["CHEMBL600"],"references":[{"source":"PubMed","ids":["18046889","2546864","26855777"],"urls":["http://europepmc.org/abstract/MED/18046889","http://europepmc.org/abstract/MED/2546864","http://europepmc.org/abstract/MED/26855777"]},{"source":"FDA","ids":["label/2004/21539_N-acetylcysteine_lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21539_N-acetylcysteine_lbl.pdf"]},{"source":"DailyMed","ids":["archives/fdaDrugInfo.cfm?archiveid=323452","archives/fdaDrugInfo.cfm?archiveid=323452","archives/fdaDrugInfo.cfm?archiveid=438110"],"urls":["https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=323452","https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=323452","https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=438110"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Keap1/Nrf2 inhibitor","chemblIds":["CHEMBL1762621"],"targetName":"Keap1/Nrf2","targetType":"protein-protein interaction","targets":["ENSG00000116044","ENSG00000079999"],"references":[{"source":"PubMed","ids":["16998237","3542979","11043571","3542979","3542979"],"urls":["http://europepmc.org/abstract/MED/16998237","http://europepmc.org/abstract/MED/3542979","http://europepmc.org/abstract/MED/11043571","http://europepmc.org/abstract/MED/3542979","http://europepmc.org/abstract/MED/3542979"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Glutamate [NMDA] receptor subunit epsilon 1 antagonist","chemblIds":["CHEMBL1201461","CHEMBL52440"],"targetName":"Glutamate [NMDA] receptor subunit epsilon 1","targetType":"single protein","targets":["ENSG00000183454"],"references":[{"source":"PubMed","ids":["2897648","2897648"],"urls":["http://europepmc.org/abstract/MED/2897648","http://europepmc.org/abstract/MED/2897648"]},{"source":"Wikipedia","ids":["Dextromethorphan","Nmda_receptor_antagonist","Dextromethorphan","Nmda_receptor_antagonist"],"urls":["http://en.wikipedia.org/wiki/Dextromethorphan","http://en.wikipedia.org/wiki/Nmda_receptor_antagonist","http://en.wikipedia.org/wiki/Dextromethorphan","http://en.wikipedia.org/wiki/Nmda_receptor_antagonist"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Smoothened homolog antagonist","chemblIds":["CHEMBL3545403"],"targetName":"Smoothened homolog","targetType":"single protein","targets":["ENSG00000128602"],"references":[{"source":"PubMed","ids":["25670876"],"urls":["http://europepmc.org/abstract/MED/25670876"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Beta-nerve growth factor inhibitor","chemblIds":["CHEMBL2108567"],"targetName":"Beta-nerve growth factor","targetType":"single protein","targets":["ENSG00000134259"],"references":[{"source":"PubMed","ids":["18505735"],"urls":["http://europepmc.org/abstract/MED/18505735"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Chondroitin-6-sulfate hydrolytic enzyme","chemblIds":["CHEMBL2108676"],"references":[{"source":"FDA","ids":["label/2014/125460s000lbl.pdf","label/2014/125460s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","chemblIds":["CHEMBL1278146"],"targetName":"Tyrosine-protein kinase receptor FLT3","targetType":"single protein","targets":["ENSG00000122025"],"references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604","10.1158/1538-7445.AM2011-3604"],"urls":["http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604","http://cancerres.aacrjournals.org/content/71/8_Supplement/3604"]},{"source":"PubMed","ids":["24043137","24043137","24043137","24043137","24043137","24043137"],"urls":["http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137","http://europepmc.org/abstract/MED/24043137"]},{"source":"ClinicalTrials","ids":["NCT02390947","NCT02390947","NCT02390947","NCT02390947","NCT02390947"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947","https://www.clinicaltrials.gov/ct2/show/NCT02390947"]}]}
{"actionType":"RNAI INHIBITOR","mechanismOfAction":"Nucleoprotein mRNA RNAi inhibitor","chemblIds":["CHEMBL3137338"],"references":[{"source":"PubMed","ids":["19506055","20421463","32561705"],"urls":["http://europepmc.org/abstract/MED/19506055","http://europepmc.org/abstract/MED/20421463","http://europepmc.org/abstract/MED/32561705"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Envelope glycoprotein inhibitor","chemblIds":["CHEMBL4298184"],"targetName":"Envelope glycoprotein","targetType":"single protein","targets":[],"references":[{"source":"FDA","ids":["label/2020/761169s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761169s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Penicillin-binding protein inhibitor","chemblIds":["CHEMBL1201041","CHEMBL1537"],"targetName":"Penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"PubMed","ids":["2515794"],"urls":["http://europepmc.org/abstract/MED/2515794"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Thymidylate synthase inhibitor","chemblIds":["CHEMBL2360464","CHEMBL225072"],"targetName":"Thymidylate synthase","targetType":"single protein","targets":["ENSG00000176890"],"references":[{"source":"DailyMed","ids":["setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13","setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13","setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Type-1 angiotensin II receptor antagonist","chemblIds":["CHEMBL1200670","CHEMBL938"],"targetName":"Type-1 angiotensin II receptor","targetType":"single protein","targets":["ENSG00000144891"],"references":[{"source":"Wikipedia","ids":["Angiotensin_receptor"],"urls":["http://en.wikipedia.org/wiki/Angiotensin_receptor"]},{"source":"PubMed","ids":["603879"],"urls":["http://europepmc.org/abstract/MED/603879"]}]}
{"actionType":"POSITIVE ALLOSTERIC MODULATOR","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","chemblIds":["CHEMBL3989724","CHEMBL968"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"Wikipedia","ids":["Flurazepam"],"urls":["http://en.wikipedia.org/wiki/Flurazepam"]},{"source":"PubMed","ids":["2863335"],"urls":["http://europepmc.org/abstract/MED/2863335"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Envelope phospholipase F13 (p37) inhibitor","chemblIds":["CHEMBL1257073"],"targetName":"Envelope phospholipase F13 (p37)","targetType":"single protein","targets":[],"references":[{"source":"FDA","ids":["label/2018/208627s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208627s000lbl.pdf"]},{"source":"PubMed","ids":["16189015"],"urls":["http://europepmc.org/abstract/MED/16189015"]}]}
{"actionType":"DISRUPTING AGENT","mechanismOfAction":"Cell membrane disrupting agent","chemblIds":["CHEMBL1275802"],"references":[{"source":"PubMed","ids":["19010301","33133056"],"urls":["http://europepmc.org/abstract/MED/19010301","http://europepmc.org/abstract/MED/33133056"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"DNA cross-linking agent","chemblIds":["CHEMBL167731"],"references":[{"source":"PubMed","ids":["19720735","25929194"],"urls":["http://europepmc.org/abstract/MED/19720735","http://europepmc.org/abstract/MED/25929194"]}]}
{"actionType":"DISRUPTING AGENT","mechanismOfAction":"DNA disrupting agent","chemblIds":["CHEMBL25336"],"references":[{"source":"PubMed","ids":["7053862","32601311"],"urls":["https://pubmed.ncbi.nlm.nih.gov/7053862/","https://pubmed.ncbi.nlm.nih.gov/32601311/"]}]}
